CI The Cigna Group Common Stock
เกี่ยวกับ The Cigna Group Common Stock ภาพรวมบริษัทจาก Wikipedia
The Cigna Group is an American multinational for-profit managed healthcare and insurance company based in Bloomfield, Connecticut. Cigna's insurance subsidiaries are major providers of medical, dental, disability, life and accident insurance and related products and services, the majority of which are offered through employers and other groups.
อ่านเพิ่มเติม
The Cigna Group is an American multinational for-profit managed healthcare and insurance company based in Bloomfield, Connecticut. Cigna's insurance subsidiaries are major providers of medical, dental, disability, life and accident insurance and related products and services, the majority of which are offered through employers and other groups (e.g., governmental and non-governmental organizations, unions and associations).
Cigna is incorporated in Delaware. The company ranked No. 15 in the 2023 Fortune 500 list of the largest U.S. corporations by total revenue, and the company took 68th place in the 2023 Forbes Global 2000 ranking. It has been embroiled in controversies, including engaging in automatic denials of insurance claims without reviewing them.
History
Cigna was formed by the 1982 merger of the Connecticut General Life Insurance Company (CG) and INA Corporation (the parent corporation of Insurance Company of North America, the first stock insurance company in America). The company name, Cigna, is a mix of letters from the merging companies, CG and INA. Insurance Company of North America was formed in 1792, while CG was created in 1865 by a special act of the Governor of Connecticut. In October 1871, the great Chicago Fire burned for two days, destroyed 2,000 acres, and left 100,000 people in Illinois homeless. INA paid $650,000, one of only 51 insurance companies (out of a total of 202) to pay claims in full.
Cigna sold the majority of its life insurance operations to Lincoln National Corporation in 1997.
In October 2011, Cigna agreed to buy HealthSpring Inc. for $3.8 billion to jump-start its business selling Medicare plans from 46,000 Medicare Advantage members to almost 400,000 Medicare Advantage members. The payment would come from an issue of new equity to cover about 20 percent of the value, with the rest funded by additional cash and debt. In 2013, Cigna operated in 30 countries, had approximately 35,800 employees and managed around US$53.734 billion in assets.
In June 2015, U.S. health insurer Anthem Inc. announced that it would acquire Cigna for $47 billion in cash and stock. Anthem confirmed it had reached a deal to buy Cigna on July 24, 2015. On July 21, 2016, the US Justice Department filed an antitrust suit to block the proposed merger, and a District Court ruling on February 8, 2017, blocked the merger on anticompetitive grounds. That month, Cigna Corp. called off its $48 billion merger agreement with Anthem Inc., with Anthem stating it would "continue to enforce its rights under the merger agreement and remains committed to closing the transaction." After exhausting federal appeals of the antitrust merger block, the companies turned on each other in Delaware's Court of Chancery. The legal saga came to an end with an August 31, 2020 decision denying both companies claims for compensation from the other for the failed merger.
On March 7, 2018, it was announced that Cigna would acquire Express Scripts in a $67 billion deal and on August 24, 2018, the shareholders of Cigna and Express Scripts approved the deal.
In June 2020, Cigna formed a strategic alliance with Priority Health to make comprehensive health care coverage more affordable and accessible to Michigan employers and customers.
In September 2020, Cigna rebranded its health services portfolio under the name Evernorth, which included Express Scripts, Accredo, and eviCore.
In October 2020, it was announced that Cigna and Envision Healthcare had renewed their agreement to include Envision's clinicians as in-network providers for Cigna's members. In 2021, Molina Healthcare acquired Cigna's Medicaid contracts in Texas for US$60 million.
On February 13, 2023, Cigna renamed its holding company The Cigna Group, its health benefits provider business unit Cigna Healthcare, and its Evernorth business unit Evernorth Health Services.
In January 2024, the company agreed with the Health Care Service Corporation (HCSC) to sell Cigna Group's Medicare Advantage, Cigna Supplemental Benefits, Medicare Part D, and CareAllies businesses. The total value of the transaction is about $3.7 billion. The deal also included a four-year service agreement under which Evernorth Health Services, a subsidiary of the Cigna Group, will continue to provide pharmacy benefits to Medicare beneficiaries. The deal closed on March 19, 2025.
On 8 July 2025, HCSC announced that its newly acquired Cigna Medicare Advantage products will be renamed Healthspring, which was a dormant brand name acquired as part of HCSC deal with the Cigna Group. A logo and website for the newly revived Healthspring brand have already been launched by HCSC, which now owns Healthspring.
Cigna Global Health Benefits
Cigna Global Health Benefits is a business unit within Cigna. The company is headquartered in Wilmington, Delaware, close to Philadelphia. Additional Cigna Global Health Benefits operations are located in Visalia, California, and Greenock, Scotland and Shanghai, China and Antwerp, Belgium. Sales offices are located in North America, Europe, Asia and the Middle East.
Products and services
CGHB global health plans typically include medical, dental, behavioral, and disability coverage, as well as business travel and life insurance components. Expatriates are defined as employees of multinational companies who work outside their home country on short- or long-term international assignments. CGHB maintains its own, in-house international claims platform, and offers a network of physicians and hospitals for its members (including 550,000 in the U.S. and more than 141,000 outside the U.S.).
Public relations and lobbying
Cigna spent more than $4.4 million from 2005 to 2009 on lobbying to attain legislation that the company favors. This includes $720,000 spent in 2009 alone, when it had 20 lobbyists at five firms working on its behalf.
In 2008, the head of Cigna's public relations, Wendell Potter, resigned, becoming a whistleblower who gave testimony in 2009 to the U.S. Senate Committee on Commerce, Science and Transportation in favor of reform of the health care industry.
Controversies
Automatically rejecting claims with no review
In 2023, Cigna was criticized for allowing company doctors to reject claims even if they had not opened the patient's file. The company was found to be using a system, "PXDX," that, according to ProPublica, "saved money in two ways. It allowed Cigna to begin turning down claims that it had once paid. And it made it cheaper to turn down claims, because the company's doctors never had to open a file or conduct any in-depth review. They simply denied the claims in bulk with an electronic signature." The speed with which denials were placed was termed internally as "click and close."
Nataline Sarkisyan liver transplant case
In December 2007, Cigna refused to pay for a liver transplant of a California teenage girl, Nataline Sarkisyan, coming under scrutiny as a result. There was a liver ready and waiting to be transplanted, and doctors estimated she had a 65% chance of surviving at least six months. In response to much protest and public scrutiny, Cigna reversed its decision, though Ms. Sarkisyan died awaiting the transplant.
Even though liver transplants have been performed since 1963 and are a well-accepted treatment option for end-stage liver disease and acute liver failure, Cigna defended its actions by claiming that there was insufficient data to show that a transplant for a patient in Sarkisyan's condition would be safe and effective. The California court agreed with Cigna's position that the Sarkisyans’ claims regarding Cigna's decision-making were preempted by federal ERISA law. On April 16, 2009, the United States District Court for the Central District of California dismissed all of the claims against Cigna related to the coverage determination.
The UK newspaper The Guardian in their Esc and Ctrl videoblog about control of the Internet by corporations, documented the incident with Nataline Sarkisyan and the former vice president of Cigna talking about astroturfing, the practice of creating fake blogs by interested groups, e.g. health insurance companies, to push claims that are profitable for said company into media, e.g. dismissing universal health care.
Other controversies
In 2002, Cigna was alleged in violation of the Securities Exchange Act for earnings manipulation. Its common stock price plummeted significantly as a result.
In 2015, the American Consumer Satisfaction Index named Cigna as one of the most hated companies in the U.S. Cigna's name returned on the ACSI's most hated list in 2018.
In August 2020, the Department of Justice filed a lawsuit against Cigna alleging that the company defrauded Medicare Advantage, Medicare, and Medicaid for $1.4B by submitting diagnostic codes for health conditions that patients did not have.
In November 2020, investors sued Cigna's CEO and board, alleging that they had used "black-ops-style" tactics to "blow up" the potential merger with Anthem in 2017. One pension fund accused Cigna CEO David Cordani of seeking to poison the deal after he had failed to secure the top post in the resulting company. The fund claimed he had utilized lawyers and public relations specialists to set up a "Trojan Horse" campaign. The merger would have produced the largest U.S. health insurer in 2017.
Evaluations
Cigna received gold in the 2009 Gartner & 1to1 Customer Experience Excellence Award. The awards are given to the companies that "most clearly demonstrate exemplary customer relationship strategy and an unrivaled level of excellence in delivering the customer experience".
In January 2010, Cigna received the JD Power award for customer service for all of its call centers for the fourth time in a row.
In 2011, the California Nurses Association determined that Cigna denied roughly 39.6% of all claims (compared to competitors such as Aetna, who denied about 5.9% of all claims in the same time frame).
Strategic alliances
On April 16, 2010, Cigna announced an alliance with Humana group to offer a streamlined Medicare Advantage offering through employer clients for retirees. In November 2023, Reuters reported that Cigna and Humana were in talk to merge, in a deal totalling $60 billion. In December 2023, The Wall Street Journal reported that merger talks ended.
In November 2011, Cigna and TTK Group, an Indian business conglomerate focused on healthcare, formed a joint venture called Cigna TTK to develop a health insurance business in India, subject to obtaining government approvals.
แหล่งที่มา: Wikipedia (ภาษาอังกฤษ), CC BY-SA 4.0 · ดูบน Wikipedia ↗
CI ภาพรวมหุ้น ราคา, มูลค่าหลักทรัพย์ตามราคาตลาด, P/E, EPS, ROE, อัตราส่วนหนี้สินต่อทุน, ช่วงราคา 52 สัปดาห์
CI กราฟราคาหุ้น OHLCV รายวันพร้อมตัวชี้วัดทางเทคนิค — แพน ซูม และปรับแต่งมุมมองของคุณ
ผลการดำเนินงาน 10 ปี แนวโน้มรายได้ กำไรสุทธิ อัตรากำไร และ EPS
การประเมินมูลค่า อัตราส่วน P/E, P/S, P/B, EV/EBITDA — หุ้นมีราคาแพงหรือถูก?
ความสามารถในการทำกำไร อัตรากำไรขั้นต้น, อัตรากำไรจากการดำเนินงาน และอัตรากำไรสุทธิ; ROE, ROA, ROIC
สุขภาพทางการเงิน หนี้สิน, สภาพคล่อง, ความสามารถในการชำระหนี้ — ความแข็งแกร่งของงบดุล
การเติบโต การเติบโตของรายได้, EPS และกำไรสุทธิ: YoY, CAGR 3 ปี, CAGR 5 ปี
ประสิทธิภาพของเงินทุน อัตราหมุนเวียนสินทรัพย์, อัตราหมุนเวียนสินค้าคงคลัง, อัตราหมุนเวียนลูกหนี้
เงินปันผล ผลตอบแทน, อัตราการจ่ายเงินปันผล, ประวัติเงินปันผล, CAGR 5 ปี
| วันที่ไม่ได้รับสิทธิปันผล | จำนวน |
|---|---|
| 4 มิถุนายน 2026 | $1.5600 |
| 5 มีนาคม 2026 | $1.5600 |
| 4 ธันวาคม 2025 | $1.5100 |
| 4 กันยายน 2025 | $1.5100 |
| 3 มิถุนายน 2025 | $1.5100 |
| 5 มีนาคม 2025 | $1.5100 |
| 4 ธันวาคม 2024 | $1.4000 |
| 4 กันยายน 2024 | $1.4000 |
| 4 มิถุนายน 2024 | $1.4000 |
| 5 มีนาคม 2024 | $1.4000 |
| 5 ธันวาคม 2023 | $1.2300 |
| 5 กันยายน 2023 | $1.2300 |
| 6 มิถุนายน 2023 | $1.2300 |
| 7 มีนาคม 2023 | $1.2300 |
| 5 ธันวาคม 2022 | $1.1200 |
| 6 กันยายน 2022 | $1.1200 |
| 7 มิถุนายน 2022 | $1.1200 |
| 8 มีนาคม 2022 | $1.1200 |
| 6 ธันวาคม 2021 | $1.0000 |
| 7 กันยายน 2021 | $1.0000 |
CI ความเห็นหลายต่อหลายของนักวิเคราะห์ มุมมองนักวิเคราะห์ทั้งเชิงบวกและเชิงลบ, ราคาเป้าหมาย 12 เดือน, อัพไซด์
- ซื้อแนะนำ 11 32.4%
- ซื้อ 16 47.1%
- ถือ 7 20.6%
- ขาย 0 0.0%
- ขายแนะนำ 0 0.0%
ราคาเป้าหมาย 12 เดือน
24 นักวิเคราะห์ · 2026-08-21ประวัติผลประกอบการ EPS จริงเทียบกับประมาณการ, เปอร์เซ็นต์ส่วนต่าง%, อัตราการชนะ, วันประกาศผลประกอบการครั้งถัดไป
| งวด | EPS Actual | EPS คาด | ส่วนต่าง |
|---|---|---|---|
| 30 มิถุนายน 2026 | $7.78 | $7.83 | -0.05% |
| 31 มีนาคม 2026 | $7.79 | $7.84 | -0.05% |
| 31 ธันวาคม 2025 | $8.08 | $8.11 | -0.03% |
| 30 กันยายน 2025 | $7.83 | $7.88 | -0.05% |
| 30 มิถุนายน 2025 | $7.20 | $7.37 | -0.17% |
| 31 มีนาคม 2025 | $6.74 | $6.54 | 0.20% |
การเปรียบเทียบกับบริษัทคู่เทียบ (อุตสาหกรรมย่อย GICS) เมตริกสำคัญเทียบกับบริษัทในกลุ่มอุตสาหกรรมเดียวกัน
| Ticker | มูลค่าตลาด | P/E | รายได้ YoY | อัตรากำไรสุทธิ | ROE | อัตรากำไรขั้นต้น |
|---|---|---|---|---|---|---|
| CI | $72.51B | 12.4 | 11.2% | 2.2% | 14.4% | — |
| CVS | $100.87B | 57.1 | 7.8% | 0.44% | 2.4% | — |
| LH | $20.62B | 24.0 | 7.2% | 6.3% | 10.3% | 28.8% |
| DGX | $19.09B | 19.8 | 11.8% | 9.0% | 14.2% | — |
| GH | $13.34B | -30.8 | 32.9% | -42.4% | 205.7% | — |
| LH | $20.62B | 24.0 | 7.2% | 6.3% | 10.3% | 28.8% |
| BTSG | $7.20B | 43.0 | 28.2% | 1.5% | 10.8% | 11.8% |
| DVA | $7.79B | 11.5 | 6.5% | 5.5% | -281.8% | — |
| HIMS | — | 63.7 | 59.0% | 5.5% | 23.3% | 73.8% |
| HNGE | $0 | -6.0 | 50.6% | -89.9% | -299.8% | 79.7% |
| CHE | — | 23.3 | 4.1% | 10.5% | 24.4% | — |
ปัจจัยพื้นฐานฉบับเต็ม ตัวชี้วัดทั้งหมดรายปี — งบกำไรขาดทุน, งบดุล, งบกระแสเงินสด
งบกำไรขาดทุน 12
| ตัวชี้วัด | แนวโน้ม | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $274.90B | $247.12B | $195.26B | $180.52B | $174.07B | $160.40B | $153.57B | $48.65B | $41.81B | $39.84B | |
| Cost of Revenue | $214.99B | $182.51B | $133.80B | $124.83B | $117.55B | $103.48B | $97.67B | $4.79B | $2.46B | $2.47B | |
| SG&A Expense | $14.62B | $14.84B | $14.82B | $13.17B | $13.01B | $14.07B | $14.05B | $11.93B | $10.03B | $9.79B | |
| Operating Income | $9.20B | $9.42B | $8.54B | $8.45B | $7.94B | $8.15B | $8.08B | $4.16B | $3.94B | $3.09B | |
| Other Non-op | $-1.41B | $-1.44B | $-1.45B | $-1.23B | $-1.21B | $-1.44B | $-1.68B | $-498M | $-252M | $-278M | |
| Pretax Income | $7.78B | $5.27B | $5.51B | $8.40B | $6.79B | $10.87B | $6.57B | $3.58B | $3.61B | $2.98B | |
| Income Tax | $1.49B | $1.49B | $141M | $1.61B | $1.37B | $2.38B | $1.45B | $935M | $1.37B | $1.14B | |
| Net Income | $5.96B | $3.43B | $5.16B | $6.78B | $5.42B | $8.49B | $5.12B | $2.65B | $2.23B | $1.84B | |
| EPS (Basic) | $22.33 | $12.25 | $17.57 | $21.66 | $15.89 | $23.17 | $13.58 | $10.69 | $8.92 | $7.31 | |
| EPS (Diluted) | $22.18 | $12.12 | $17.39 | $21.41 | $15.75 | $22.96 | $13.44 | $10.54 | $8.77 | $7.19 | |
| Shares (Diluted) | 268,563,000 | 283,218,000 | 296,882,000 | 313,065,000 | 340,966,000 | 368,389,000 | 379,817,000 | 250,225,000 | 255,072,000 | 259,647,000 | |
| EBITDA | $11.97B | $12.19B | $11.57B | $11.35B | $10.86B | $10.96B | $11.73B | $4.86B | · | · |
งบดุล 29
| ตัวชี้วัด | แนวโน้ม | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $7.68B | $7.55B | $7.82B | $5.92B | $5.08B | $10.18B | $4.62B | $3.85B | $2.97B | $3.19B | |
| Short-term Investments | $1.06B | $665M | $925M | $905M | $920M | $1.33B | $937M | $2.04B | $2.14B | · | |
| Receivables | $28.77B | $24.23B | $17.72B | $17.22B | $15.07B | $12.19B | $10.72B | $10.47B | $3.15B | · | |
| Inventory | $7.34B | $6.69B | $5.64B | $4.78B | $3.72B | $3.17B | $2.66B | $2.82B | $228M | · | |
| Other Current Assets | $2.98B | $2.73B | $2.17B | $1.30B | $1.28B | $930M | $1.40B | $1.24B | $820M | · | |
| Current Assets | $47.81B | $48.87B | $37.35B | $30.12B | $36.13B | $27.80B | $29.84B | $20.43B | $9.31B | · | |
| PP&E (Net) | $3.65B | · | · | $3.77B | $3.69B | $4.21B | $4.42B | $4.56B | $1.56B | · | |
| PP&E (Gross) | $13.75B | · | · | $11.20B | $10.28B | $9.78B | $8.92B | $7.96B | $4.61B | · | |
| Accum. Depreciation | $10.10B | · | · | $7.43B | $6.59B | $5.58B | $4.50B | $3.40B | $3.05B | · | |
| Goodwill | $44.92B | $44.37B | $44.26B | $45.81B | $45.81B | $44.65B | $44.60B | $44.51B | $6.16B | $5.98B | |
| Intangibles | $28.56B | $29.42B | $30.86B | $32.49B | $34.10B | $35.18B | $36.56B | $39.00B | $345M | · | |
| Other Non-current Assets | $2.88B | $2.79B | $3.42B | $2.70B | $3.40B | $2.69B | $2.28B | $1.63B | $1.43B | · | |
| Total Assets | $157.92B | $155.88B | $152.76B | $143.88B | $154.89B | $155.45B | $155.77B | $153.23B | $61.76B | · | |
| Accounts Payable | $10.66B | $9.29B | $8.55B | $7.78B | $6.66B | $5.48B | $5.09B | $4.37B | $184M | · | |
| Short-term Debt | $0 | $880M | $1.24B | $0 | $2.03B | $1.03B | $944M | $1.50B | $100M | · | |
| Current Liabilities | $56.34B | $57.98B | $48.72B | $41.23B | $43.57B | $36.02B | $40.14B | $31.89B | $11.01B | · | |
| Capital Leases | · | · | $340M | $346M | · | $491M | $465M | · | · | · | |
| Deferred Tax | $7.14B | $6.97B | $7.17B | $7.79B | $8.35B | $8.94B | $9.39B | $9.45B | $0 | · | |
| Other Non-current Liabilities | $4.24B | $3.21B | $3.44B | $2.77B | $3.76B | $4.63B | $4.46B | $3.47B | $2.84B | · | |
| Total Liabilities | $116.05B | $114.64B | $106.41B | $99.13B | $107.70B | $105.06B | $110.39B | $112.15B | $48.00B | · | |
| Long-term Debt | · | · | · | · | · | · | · | $39.52B | · | · | |
| Total Debt | $0 | $880M | $1.24B | $0 | $2.03B | $1.03B | $944M | $1.50B | · | · | |
| Common Stock | $4M | $4M | $4M | $4M | $4M | $4M | $4M | $4M | $74M | · | |
| Retained Earnings | $47.87B | $43.52B | $41.65B | $37.94B | $32.59B | $28.57B | $20.16B | $15.09B | $15.80B | · | |
| Treasury Stock | $35.14B | $31.44B | $24.24B | $21.84B | $14.18B | $6.37B | $2.19B | $104M | $4.02B | · | |
| AOCI | $-2.81B | $-2.34B | $-1.86B | $-1.66B | $-884M | $-861M | $-941M | $-1.71B | $-1.08B | · | |
| Stockholders' Equity | $41.71B | $41.03B | $46.22B | $44.67B | $47.11B | $50.32B | $45.34B | $41.03B | $13.71B | · | |
| Liabilities + Equity | $157.92B | $155.88B | $152.76B | $143.88B | $154.89B | $155.45B | $155.77B | $153.23B | $61.76B | · | |
| Shares Outstanding | 263,464,000 | 273,789,000 | 292,504,000 | 298,676,000 | 322,948,000 | 354,771,000 | 372,531,000 | 380,924,000 | 0 | 0 |
กระแสเงินสด 18
| ตัวชี้วัด | แนวโน้ม | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $2.77B | $2.77B | $3.04B | $2.94B | $2.92B | $2.80B | $3.65B | $695M | $566M | $610M | |
| Deferred Tax | $326M | $-95M | $-1.66B | $-472M | $-216M | $-386M | $-313M | $-101M | $242M | $74M | |
| Amort. of Intangibles | $1.74B | $1.70B | $1.82B | $1.88B | $2.00B | $1.98B | $2.95B | $235M | $115M | $151M | |
| Restructuring | · | $0 | $252M | $22M | $168M | · | · | · | · | · | |
| Other Non-cash | $543M | $3.90B | $5.07B | $-547M | $-927M | $-555M | $1.03B | $530M | · | · | |
| Operating Cash Flow | $9.60B | $10.36B | $11.81B | $8.66B | $7.19B | $10.35B | $9.48B | $3.77B | $4.09B | $4.03B | |
| CapEx | · | · | · | · | · | · | $1.05B | $528M | $471M | $461M | |
| Investing Cash Flow | $-4.41B | $-2.10B | $-5.17B | $3.10B | $-3.61B | $2.98B | $-734M | $-26.38B | $-1.70B | $-2.57B | |
| Debt Issued | $4.46B | $4.46B | $1.49B | $0 | $4.26B | $3.46B | $0 | $22.86B | $1.58B | $0 | |
| Net Debt Issued | $261M | $1.46B | $-1.48B | $-500M | $-318M | $-4.58B | $-4.49B | $22.73B | · | · | |
| Stock Issued | $203M | $305M | $187M | $389M | $326M | $376M | $224M | $68M | $131M | $36M | |
| Stock Repurchased | $3.62B | $7.03B | $2.28B | $7.61B | $7.74B | $4.04B | $1.99B | $342M | $2.73B | $139M | |
| Net Stock Activity | $-3.42B | $-6.73B | $-2.10B | $-7.22B | $-7.42B | $-3.67B | $-1.76B | $-274M | · | · | |
| Dividends Paid | $1.61B | $1.57B | $1.45B | $1.38B | $1.34B | $15M | $15M | · | · | · | |
| Financing Cash Flow | $-6.42B | $-7.65B | $-4.29B | $-11.24B | $-8.21B | $-8.53B | $-7.19B | $23.52B | $-2.65B | $-225M | |
| Net Change in Cash | $-1.20B | $594M | $2.36B | $428M | $-4.70B | $4.83B | $1.56B | $883M | $-213M | $1.22B | |
| Taxes Paid | $399M | $898M | $1.47B | $1.85B | $2.24B | $1.84B | $1.78B | $1.02B | $1.04B | $1.06B | |
| Free Cash Flow | · | · | · | · | · | · | $8.44B | $3.24B | · | · |
ความสามารถในการทำกำไร 7
| ตัวชี้วัด | แนวโน้ม | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 3.4% | 3.8% | 4.4% | 4.7% | 4.6% | 5.1% | 5.3% | 8.6% | · | · | |
| Net Margin | 2.2% | 1.5% | 2.8% | 3.7% | 3.1% | 5.3% | 3.3% | 5.4% | · | · | |
| Pretax Margin | 2.8% | 2.1% | 2.8% | 4.6% | 3.9% | 6.8% | 4.3% | 7.4% | · | · | |
| EBITDA Margin | 4.4% | 4.9% | 5.9% | 6.3% | 6.2% | 6.8% | 7.6% | 10.0% | · | · | |
| ROA | 3.8% | 2.5% | 3.6% | 4.5% | 3.5% | 5.5% | 3.3% | 2.5% | · | · | |
| ROE | 14.4% | 8.7% | 11.8% | 14.7% | 11.1% | 17.8% | 11.9% | 9.7% | · | · | |
| ROIC | 17.8% | 16.1% | 17.5% | 15.1% | 12.9% | 12.4% | 13.6% | 7.2% | · | · |
สภาพคล่องและความสามารถในการชำระหนี้ 3
| ตัวชี้วัด | แนวโน้ม | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 0.8 | 0.8 | 0.8 | 0.7 | 0.8 | 0.8 | 0.7 | 0.6 | · | · | |
| Quick Ratio | 0.7 | 0.6 | 0.5 | 0.6 | 0.5 | 0.7 | 0.4 | 0.5 | · | · | |
| Debt / Equity | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | · | · |
ประสิทธิภาพ 3
| ตัวชี้วัด | แนวโน้ม | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 1.8 | 1.6 | 1.3 | 1.2 | 1.1 | 1.0 | 1.0 | 0.5 | · | · | |
| Inventory Turnover | 30.6 | 29.6 | 25.7 | 29.4 | 34.1 | 35.5 | 35.6 | 3.1 | · | · | |
| Receivables Turnover | 10.4 | 11.8 | 11.2 | 11.2 | 12.8 | 14.0 | 14.5 | 7.1 | · | · |
อัตราการเติบโต 10
| ตัวชี้วัด | แนวโน้ม | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 11.2% | 26.6% | 8.2% | 3.7% | 8.5% | · | · | · | · | · | |
| Revenue CAGR 3Y | 15.0% | 12.4% | 6.8% | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 11.4% | · | · | · | · | · | · | · | · | · | |
| EPS YoY | 83.0% | -30.3% | -18.8% | 35.9% | -31.4% | · | · | · | · | · | |
| EPS CAGR 3Y | 1.2% | -8.4% | -8.8% | · | · | · | · | · | · | · | |
| EPS CAGR 5Y | -0.69% | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | 73.5% | -33.5% | -23.9% | 25.1% | -36.1% | · | · | · | · | · | |
| Net Income CAGR 3Y | -4.2% | -14.1% | -15.3% | · | · | · | · | · | · | · | |
| Net Income CAGR 5Y | -6.8% | · | · | · | · | · | · | · | · | · | |
| Dividend CAGR 5Y | 154.8% | · | · | · | · | · | · | · | · | · |
การประเมินมูลค่า (TTM) 16
| ตัวชี้วัด | แนวโน้ม | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $274.90B | $247.12B | $195.26B | $180.52B | $174.07B | $160.40B | $153.57B | $48.65B | · | · | |
| Net Income TTM | $5.96B | $3.43B | $5.16B | $6.78B | $5.42B | $8.49B | $5.12B | $2.65B | · | · | |
| Market Cap | $72.51B | $75.60B | $87.59B | $98.96B | $74.16B | $73.86B | $76.18B | $72.35B | · | · | |
| Enterprise Value | $63.78B | $68.27B | $80.08B | $92.13B | $70.18B | $63.37B | $71.57B | $67.95B | · | · | |
| P/E | 12.4 | 22.8 | 17.2 | 15.5 | 14.6 | 9.1 | 15.2 | 18.0 | · | · | |
| P/S | 0.3 | 0.3 | 0.4 | 0.5 | 0.4 | 0.5 | 0.5 | 1.5 | · | · | |
| P/B | 1.7 | 1.8 | 1.9 | 2.2 | 1.6 | 1.5 | 1.7 | 1.8 | · | · | |
| P / Cash Flow | 7.6 | 7.3 | 7.4 | 11.4 | 10.3 | 7.1 | 8.0 | 19.2 | · | · | |
| P / FCF | · | · | · | · | · | · | 9.0 | 22.3 | · | · | |
| EV / EBITDA | 5.3 | 5.6 | 6.9 | 8.1 | 6.5 | 5.8 | 6.1 | 14.0 | · | · | |
| EV / FCF | · | · | · | · | · | · | 8.5 | 21.0 | · | · | |
| EV / Revenue | 0.2 | 0.3 | 0.4 | 0.5 | 0.4 | 0.4 | 0.5 | 1.4 | · | · | |
| Dividend Yield | 2.2% | 2.1% | 1.7% | 1.4% | 1.8% | 0.02% | 0.02% | · | · | · | |
| Earnings Yield | 8.1% | 4.4% | 5.8% | 6.5% | 6.9% | 11.0% | 6.6% | 5.5% | · | · | |
| Payout Ratio | 27.0% | 41.5% | 27.0% | 20.5% | 24.8% | · | · | · | · | · | |
| Annual Payout | $1.61B | $1.57B | $1.45B | $1.38B | $1.34B | $15M | $15M | · | · | · |
งบกำไรขาดทุน 12
| ตัวชี้วัด | แนวโน้ม | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $71.67B | $68.49B | $72.47B | $69.75B | $67.18B | $65.50B | $65.65B | $63.69B | $60.52B | $57.26B | $51.11B | $49.05B | $48.59B | $46.52B | $45.75B | $45.28B | |
| Cost of Revenue | $56.70B | $54.10B | $57.80B | $55.53B | $53.27B | $48.40B | $49.02B | $47.56B | $44.49B | $41.43B | $35.26B | $33.64B | $33.44B | $31.46B | $32.09B | $31.78B | |
| SG&A Expense | $3.47B | $3.72B | $3.61B | $3.36B | $3.43B | $4.21B | $3.87B | $3.59B | $3.68B | $3.71B | $4.06B | $3.79B | $3.43B | $3.54B | $3.48B | $3.15B | |
| Operating Income | $2.68B | $2.36B | $2.35B | $2.58B | $2.31B | $1.97B | $2.17B | $2.58B | $2.41B | $2.26B | $2.06B | $2.24B | $2.22B | $2.02B | $1.75B | $2.14B | |
| Other Non-op | $-356M | $-357M | $-362M | $-347M | $-337M | $-362M | $-362M | $-376M | $-375M | $-322M | $-360M | $-365M | $-363M | $-358M | $-324M | $-304M | |
| Pretax Income | $2.26B | $2.27B | $1.82B | $2.29B | $2.02B | $1.65B | $2.01B | $1.19B | $1.99B | $79M | $188M | $1.84B | $1.88B | $1.60B | $1.36B | $3.49B | |
| Income Tax | $382M | $409M | $543M | $322M | $389M | $239M | $473M | $367M | $360M | $291M | $-919M | $391M | $374M | $295M | $136M | $713M | |
| Net Income | $1.66B | $1.65B | $943M | $1.97B | $1.53B | $1.32B | $1.19B | $825M | $1.63B | $-212M | $899M | $1.45B | $1.51B | $1.31B | $1.22B | $2.78B | |
| EPS (Basic) | $6.31 | $6.30 | $4.67 | $7.02 | $5.76 | $4.88 | $5.06 | $2.65 | $5.51 | $-0.97 | $3.54 | $4.79 | $4.96 | $4.28 | $3.89 | $9.07 | |
| EPS (Diluted) | $6.29 | $6.26 | $4.64 | $6.98 | $5.71 | $4.85 | $5.01 | $2.63 | $5.45 | $-0.97 | $3.49 | $4.74 | $4.92 | $4.24 | $3.82 | $8.97 | |
| Shares (Diluted) | 263,962,000 | 264,017,000 | -540,074,000 | 267,530,000 | 268,154,000 | 272,953,000 | -568,695,000 | 281,396,000 | 284,052,000 | 286,465,000 | -596,127,000 | 297,131,000 | 296,879,000 | 298,999,000 | -634,038,000 | 307,517,000 | |
| EBITDA | $3.33B | $3.01B | · | $3.27B | $2.99B | $2.65B | · | $2.58B | $2.41B | $3.00B | · | $2.24B | $2.22B | $2.76B | · | $2.14B |
งบดุล 28
| ตัวชี้วัด | แนวโน้ม | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $6.30B | $7.04B | $7.68B | $6.03B | $4.33B | $8.33B | $7.55B | $5.89B | $6.79B | $8.44B | · | $8.50B | $9.59B | $7.93B | · | $7.08B | |
| Short-term Investments | $959M | $812M | $1.06B | $883M | $813M | $727M | $665M | $864M | $1.07B | $1.11B | · | $1.05B | $872M | $914M | · | $783M | |
| Receivables | $30.80B | $26.61B | $28.77B | $31.71B | $31.15B | $26.93B | $24.23B | $27.85B | $25.11B | $20.56B | · | $19.08B | $18.33B | $17.70B | · | $17.27B | |
| Inventory | $5.85B | $5.83B | $7.34B | $5.63B | $5.97B | $5.18B | $6.69B | $5.08B | $5.17B | $4.63B | · | $4.42B | $4.51B | $4.21B | · | $4.02B | |
| Other Current Assets | $3.09B | $2.74B | $2.98B | $2.49B | $2.47B | $2.39B | $2.73B | $2.67B | $2.66B | $2.26B | · | $1.48B | $1.41B | $1.26B | · | $1.02B | |
| Current Assets | $46.99B | $43.03B | $47.81B | $46.73B | $44.72B | $43.55B | $48.87B | $49.22B | $46.22B | $43.36B | · | $34.52B | $34.71B | $32.03B | · | $30.17B | |
| PP&E (Net) | · | · | $3.65B | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| PP&E (Gross) | · | · | $13.75B | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Accum. Depreciation | · | · | $10.10B | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Goodwill | $45.53B | $45.53B | $44.92B | $44.92B | $44.38B | $44.37B | $44.37B | $44.37B | $44.26B | $44.26B | $44.26B | $45.81B | $45.81B | $45.81B | $45.81B | $45.81B | |
| Intangibles | $26.93B | $27.32B | $28.56B | $28.98B | $28.67B | $29.05B | $29.42B | $29.79B | $30.18B | $30.49B | · | $31.32B | $31.71B | $32.10B | · | $32.88B | |
| Other Non-current Assets | $3.32B | $3.25B | $2.88B | $3.39B | $2.93B | $3.00B | $2.79B | $3.18B | $3.28B | $3.29B | · | $3.15B | $2.50B | $2.56B | · | $2.48B | |
| Total Assets | $157.08B | $153.27B | $157.92B | $157.92B | $151.65B | $150.66B | $155.88B | $157.64B | $155.45B | $153.12B | · | $149.65B | $150.05B | $147.98B | · | $144.21B | |
| Accounts Payable | $10.41B | $9.88B | $10.66B | $9.35B | $9.94B | $9.14B | $9.29B | $8.52B | $9.28B | $8.12B | · | $7.67B | $8.07B | $7.36B | · | $6.87B | |
| Short-term Debt | $1.00B | · | $0 | · | · | $0 | $880M | $1.64B | $790M | $884M | · | $1.51B | $200M | · | · | $0 | |
| Current Liabilities | $55.56B | $52.61B | $56.34B | $56.45B | $56.78B | $55.74B | $57.98B | $57.06B | $55.37B | $51.98B | · | $47.06B | $47.34B | $44.73B | · | $41.12B | |
| Capital Leases | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $368M | |
| Deferred Tax | $6.73B | $6.85B | $7.14B | $7.00B | $6.78B | $6.88B | $6.97B | $6.79B | $6.95B | $7.03B | · | $7.48B | $7.59B | $7.71B | · | $7.78B | |
| Other Non-current Liabilities | $5.61B | $4.77B | $4.24B | $3.87B | $3.65B | $3.58B | $3.21B | $3.03B | $3.54B | $3.65B | · | $2.93B | $2.58B | $2.69B | · | $3.18B | |
| Total Liabilities | $114.17B | $110.82B | $116.05B | $115.91B | $111.22B | $110.24B | $114.64B | $115.34B | $113.92B | $111.77B | · | $103.88B | $104.53B | $103.38B | · | $99.08B | |
| Total Debt | $1.00B | · | · | · | · | $0 | · | $1.64B | $790M | $884M | · | $1.51B | $200M | · | · | $0 | |
| Common Stock | $4M | $4M | $4M | $4M | $4M | $4M | $4M | $4M | $4M | $4M | · | $4M | $4M | $4M | · | $4M | |
| Retained Earnings | $50.35B | $49.11B | $47.87B | $47.03B | $45.56B | $44.43B | $43.52B | $42.48B | $42.13B | $40.98B | · | $40.98B | $39.94B | $38.84B | · | $37.04B | |
| Treasury Stock | $35.47B | $35.22B | $35.14B | $34.13B | $34.13B | $33.06B | $31.44B | $29.41B | $29.41B | $27.77B | · | $23.74B | $23.05B | $22.91B | · | $19.39B | |
| AOCI | $-4.36B | $-3.60B | $-2.81B | $-2.80B | $-2.82B | $-2.59B | $-2.34B | $-2.16B | $-2.44B | $-2.32B | · | $-2.12B | $-1.88B | $-1.77B | · | $-2.01B | |
| Stockholders' Equity | $42.62B | $42.21B | $41.71B | $41.80B | $40.21B | $40.23B | $41.03B | $42.09B | $41.33B | $41.18B | · | $45.69B | $45.45B | $44.50B | · | $45.04B | |
| Liabilities + Equity | $157.08B | $153.27B | $157.92B | $157.92B | $151.65B | $150.66B | $155.88B | $157.64B | $155.45B | $153.12B | · | $149.65B | $150.05B | $147.98B | · | $144.21B | |
| Shares Outstanding | · | · | 263,464,000 | · | · | · | 273,789,000 | · | · | · | 292,504,000 | · | · | · | 298,676,000 | · |
กระแสเงินสด 15
| ตัวชี้วัด | แนวโน้ม | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $655M | $650M | $722M | $697M | $682M | $674M | $646M | $650M | $738M | $741M | $765M | $766M | $755M | $749M | $735M | $726M | |
| Amort. of Intangibles | $389M | $390M | $463M | $436M | $422M | $422M | $424M | $436M | $420M | $423M | $451M | $454M | $455M | $459M | $457M | $460M | |
| Restructuring | · | · | · | $222M | $129M | $215M | · | $0 | $0 | $0 | $252M | $0 | $0 | · | $0 | $0 | |
| Other Non-cash | · | $-1.17B | · | · | · | $-163M | · | · | · | $4.31B | · | · | · | $2.97B | · | · | |
| Operating Cash Flow | $-421M | $1.13B | $6.15B | $3.42B | $-1.89B | $1.92B | $5.21B | $46M | $265M | $4.84B | $1.47B | $2.83B | $2.49B | $5.03B | $2.10B | $3.28B | |
| Investing Cash Flow | $-503M | $-637M | $-420M | $-4.39B | $-797M | $1.20B | $-191M | $-776M | $-640M | $-495M | $-440M | $-1.34B | $-414M | $-2.98B | $-616M | $4.45B | |
| Debt Issued | · | · | $-3M | $4.46B | $0 | $0 | $0 | $0 | $0 | $4.46B | $0 | $0 | $0 | $1.49B | $0 | $0 | |
| Net Debt Issued | · | $-550M | · | · | · | $-700M | · | · | · | $2.25B | · | · | · | $1.41B | · | · | |
| Stock Issued | $101M | $57M | $25M | $37M | $72M | $69M | $22M | $62M | $40M | $181M | $74M | $54M | $29M | $30M | $72M | $100M | |
| Stock Repurchased | $280M | $0 | $1.00B | $0 | $1.11B | $1.51B | $2.02B | $0 | $990M | $4.02B | $544M | $624M | $154M | $962M | $1.73B | $3.50B | |
| Net Stock Activity | · | $57M | · | · | · | $-1.44B | · | · | · | $-3.84B | · | · | · | $-932M | · | · | |
| Dividends Paid | $409M | $417M | $396M | $402M | $401M | $412M | $384M | $390M | $392M | $401M | $358M | $362M | $362M | $368M | $334M | $341M | |
| Financing Cash Flow | $207M | $-1.14B | $-4.07B | $2.66B | $-1.33B | $-3.68B | $-3.25B | $439M | $-2.31B | $-2.53B | $-1.25B | $-2.57B | $-435M | $-37M | $-2.64B | $-5.52B | |
| Net Change in Cash | $-724M | $-656M | $1.67B | $1.69B | $-3.99B | $-555M | $1.75B | $-273M | $-2.69B | $1.81B | $-209M | $-1.09B | $1.65B | $2.01B | $-1.14B | $2.19B | |
| Taxes Paid | · | · | $43M | $6M | $210M | $140M | $59M | $272M | $457M | $110M | $91M | $454M | $849M | $77M | $504M | $435M |
ความสามารถในการทำกำไร 7
| ตัวชี้วัด | แนวโน้ม | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 3.7% | 3.4% | · | 3.7% | 3.4% | 3.0% | · | 4.0% | 4.0% | 3.9% | · | 4.6% | 4.6% | 4.3% | · | 4.7% | |
| Net Margin | 2.3% | 2.4% | · | 2.8% | 2.4% | 2.1% | · | 1.3% | 2.7% | -0.37% | · | 2.9% | 3.1% | 2.8% | · | 6.1% | |
| Pretax Margin | 3.1% | 3.3% | · | 3.3% | 3.0% | 2.5% | · | 1.9% | 3.3% | 0.14% | · | 3.8% | 3.9% | 3.4% | · | 7.7% | |
| EBITDA Margin | 4.7% | 4.4% | · | 4.7% | 4.5% | 4.0% | · | 4.0% | 4.0% | 5.2% | · | 4.6% | 4.6% | 5.9% | · | 4.7% | |
| ROA | 1.1% | 1.1% | · | 1.2% | 1.1% | 0.93% | · | 0.54% | 1.1% | -0.14% | · | 0.99% | 1.0% | 0.87% | · | 1.9% | |
| ROE | 4.0% | 4.0% | · | 4.7% | 4.0% | 3.5% | · | 1.9% | 3.8% | -0.49% | · | 3.2% | 3.3% | 2.9% | · | 6.0% | |
| ROIC | 5.1% | 4.6% | · | 5.3% | 4.6% | 4.2% | · | 4.1% | 4.7% | -14.4% | · | 3.7% | 3.9% | 3.7% | · | 3.8% |
สภาพคล่องและความสามารถในการชำระหนี้ 3
| ตัวชี้วัด | แนวโน้ม | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 0.8 | 0.8 | · | 0.8 | 0.8 | 0.8 | · | 0.9 | 0.8 | 0.8 | · | 0.7 | 0.7 | 0.7 | · | 0.7 | |
| Quick Ratio | 0.7 | 0.7 | · | 0.7 | 0.6 | 0.6 | · | 0.6 | 0.6 | 0.6 | · | 0.6 | 0.6 | 0.6 | · | 0.6 | |
| Debt / Equity | 0.0 | · | · | · | · | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | · | · | 0.0 |
ประสิทธิภาพ 3
| ตัวชี้วัด | แนวโน้ม | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.5 | 0.5 | · | 0.4 | 0.4 | 0.4 | · | 0.4 | 0.4 | 0.4 | · | 0.3 | 0.3 | 0.3 | · | 0.3 | |
| Inventory Turnover | 9.6 | 9.8 | · | 10.4 | 9.6 | 9.9 | · | 10.0 | 9.2 | 9.4 | · | 8.0 | 8.1 | 8.2 | · | 9.0 | |
| Receivables Turnover | 2.3 | 2.6 | · | 2.3 | 2.4 | 2.8 | · | 2.7 | 2.8 | 3.0 | · | 2.7 | 2.7 | 2.8 | · | 2.7 |
การประเมินมูลค่า (TTM) 5
| ตัวชี้วัด | แนวโน้ม | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $277.09B | $270.92B | · | $266.12B | $256.90B | $246.97B | · | $230.52B | $215.41B | $201.41B | · | $189.43B | $185.86B | $181.28B | · | $179.05B | |
| Net Income TTM | $6.82B | $6.58B | · | $5.84B | $5.50B | $3.65B | · | $3.69B | $4.38B | $4.05B | · | $7.04B | $7.16B | $6.87B | · | $7.20B | |
| P/E | 10.9 | 11.2 | · | 14.3 | 17.7 | 27.5 | · | 29.2 | 23.4 | 28.1 | · | 12.5 | 12.2 | 11.7 | · | 12.4 | |
| Earnings Yield | 9.2% | 8.9% | · | 7.0% | 5.6% | 3.6% | · | 3.4% | 4.3% | 3.6% | · | 8.0% | 8.2% | 8.5% | · | 8.1% | |
| Payout Ratio | · | 25.2% | · | · | · | 29.2% | · | · | · | -189.2% | · | · | · | 28.2% | · | · |
งบการเงิน งบกำไรขาดทุน, งบดุล, งบกระแสเงินสด — รายปี, 5 ปีล่าสุด
งบกำไรขาดทุน
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| รายได้ | $274.90B | $247.12B | $195.26B | $180.52B | $174.07B |
| อัตรากำไรจากการดำเนินงาน % | 3.4% | 3.8% | 4.4% | 4.7% | 4.6% |
| กำไรสุทธิ | $5.96B | $3.43B | $5.16B | $6.78B | $5.42B |
| EPS ที่ปรับลดแล้ว | $22.18 | $12.12 | $17.39 | $21.41 | $15.75 |
งบดุล
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| หนี้สินต่อทุน | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| อัตราส่วนสภาพคล่อง | 0.8 | 0.8 | 0.8 | 0.7 | 0.8 |
| อัตราส่วนเงินสด | 0.7 | 0.6 | 0.5 | 0.6 | 0.5 |
ข่าวล่าสุด หัวข้อข่าวล่าสุดที่กล่าวถึงบริษัทนี้
สัญญาณซื้อขาย สัญญาณซื้อ/ขายล่าสุดพร้อมราคาเข้าและอัตราส่วนความเสี่ยง/ผลตอบแทน
ตัวชี้วัดของฉัน รายการเฝ้าดูส่วนตัวของคุณ — แถวที่เลือกจากข้อมูลพื้นฐานฉบับเต็ม
เลือกเมตริกที่สำคัญสำหรับคุณ — คลิก ➕ ถัดจากแถวใดก็ได้ในข้อมูลพื้นฐานฉบับเต็มด้านบน
การเลือกของคุณถูกบันทึกและจะติดตามคุณไปในทุกสัญลักษณ์หุ้น
ผู้ถือครองสถาบัน (13F) 1,880 รายงาน · $43.5B ทั้งหมด · ณ วันที่ 30 มิถุนายน 2026
สถาบันที่รายงานการถือครองหุ้นนี้ในเอกสาร SEC Form 13F รายไตรมาสของตน เฉพาะสถานะ Long; ผู้ยื่นคำร้องรายเดียวอาจปรากฏสองครั้งสำหรับสัญญาออปชันที่แยกจากกัน ขา put/call ขนาดใหญ่ที่หักล้างกันมักสะท้อนถึงการทำตลาด (market-making) หรือสินค้าคงคลังที่มีการป้องกันความเสี่ยง (hedged inventory) ไม่ใช่การเชื่อมั่นในทิศทาง
| พอร์ตใหม่ | ตำแหน่งที่ปิดไปแล้ว | เพิ่มขึ้น | ลดลง | การเปลี่ยนแปลงสุทธิของจำนวนหุ้น |
|---|---|---|---|---|
| 160 (-26 เทียบกับไตรมาสก่อน) | 90 (-25 เทียบกับไตรมาสก่อน) | 668 (+23 เทียบกับไตรมาสก่อน) | 583 (+4 เทียบกับไตรมาสก่อน) | +3.0M |
เปรียบเทียบกับ Q1 2026. การยื่นแบบฟอร์ม 13F ของ SEC จะครบกำหนดภายใน 45 วันนับจากสิ้นสุดไตรมาส บวกกับระยะเวลาผ่อนผันสั้นๆ สำหรับผู้ยื่นล่าช้า — ไตรมาสที่ยังอยู่ในช่วงเวลานี้จะถูกข้ามไปเพื่อใช้คู่ที่รายงานล่าสุดอย่างสมบูรณ์
| สถาบัน | มูลค่า | หุ้น | % ของ 13F ที่ติดตาม | ประเภท |
|---|---|---|---|---|
| VANGUARD CAPITAL MANAGEMENT LLC | $4,762,729,281 | 17,276,296 | 10.94% | หุ้น |
| STATE STREET CORP | $3,496,245,161 | 12,682,259 | 8.03% | หุ้น |
| Dodge & Cox | $3,356,093,871 | 12,173,875 | 7.71% | หุ้น |
| Sanders Capital, LLC | $2,796,668,015 | 10,144,617 | 6.43% | หุ้น |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $1,717,104,307 | 6,228,614 | 3.94% | หุ้น |
| GQG Partners LLC | $1,628,918,123 | 5,908,707 | 3.74% | หุ้น |
| GEODE CAPITAL MANAGEMENT, LLC | $1,480,812,562 | 5,399,567 | 3.40% | หุ้น |
| FMR LLC | $1,045,833,560 | 3,793,651 | 2.40% | หุ้น |
| NORGES BANK | $982,164,860 | 3,562,699 | 2.26% | หุ้น |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $785,495,575 | 2,849,302 | 1.80% | หุ้น |
| Grantham, Mayo, Van Otterloo & Co. LLC | $710,448,797 | 2,577,075 | 1.63% | หุ้น |
| AMERIPRISE FINANCIAL INC | $683,415,995 | 2,478,794 | 1.57% | หุ้น |
| Davis Selected Advisers | $621,243,564 | 2,253,424 | 1.43% | หุ้น |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $600,639,178 | 2,178,755 | 1.38% | หุ้น |
| DIMENSIONAL FUND ADVISORS LP | $599,490,928 | 2,174,590 | 1.38% | หุ้น |
| HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC | $558,018,223 | 2,024,152 | 1.28% | หุ้น |
| TWO SIGMA INVESTMENTS, LP | $499,838,165 | 1,813,110 | 1.15% | หุ้น |
| VANGUARD FIDUCIARY TRUST CO | $409,373,497 | 1,484,959 | 0.94% | หุ้น |
| Capital World Investors | $365,436,721 | 1,325,583 | 0.84% | หุ้น |
| Capital Research Global Investors | $340,312,625 | 1,234,448 | 0.78% | หุ้น |
| VICTORY CAPITAL MANAGEMENT INC | $297,765,000 | 1,080,111 | 0.68% | หุ้น |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $295,639,232 | 1,072,400 | 0.68% | สัญญาซื้อล่วงหน้า |
| BloombergSen Inc. | $250,400,144 | 908,300 | 0.58% | สัญญาซื้อล่วงหน้า |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $241,311,801 | 875,333 | 0.55% | หุ้น |
| BlackRock, Inc. | $229,573,898 | 832,755 | 0.53% | หุ้น |
| RAYMOND JAMES FINANCIAL INC | $223,834,542 | 811,936 | 0.51% | หุ้น |
| National Pension Service | $218,948,088 | 794,211 | 0.50% | หุ้น |
| NORDEA INVESTMENT MANAGEMENT AB | $217,176,543 | 782,731 | 0.50% | หุ้น |
| Sumitomo Mitsui Trust Group, Inc. | $210,159,410 | 762,331 | 0.48% | หุ้น |
| Swiss National Bank | $205,012,464 | 743,661 | 0.47% | หุ้น |
| LYRICAL ASSET MANAGEMENT LP | $204,993,443 | 743,592 | 0.47% | หุ้น |
| Caisse de depot et placement du Quebec | $195,590,549 | 709,484 | 0.45% | หุ้น |
| Swedbank AB | $189,698,992 | 688,113 | 0.44% | หุ้น |
| NEUBERGER BERMAN GROUP LLC | $187,717,903 | 679,907 | 0.43% | หุ้น |
| BNP PARIBAS FINANCIAL MARKETS | $186,022,799 | 674,778 | 0.43% | หุ้น |
| Legal & General Group Plc | $182,534,897 | 662,126 | 0.42% | หุ้น |
| Mitsubishi UFJ Asset Management Co., Ltd. | $177,364,388 | 643,370 | 0.41% | หุ้น |
| Vanguard Global Advisers, LLC | $173,779,299 | 630,366 | 0.40% | หุ้น |
| Focused Investors LLC | $172,548,112 | 625,900 | 0.40% | หุ้น |
| GOLDMAN SACHS GROUP INC | $166,646,906 | 604,494 | 0.38% | หุ้น |
| VANGUARD ASSET MANAGEMENT, Ltd | $163,250,253 | 592,173 | 0.38% | หุ้น |
| PZENA INVESTMENT MANAGEMENT LLC | $154,942,084 | 562,036 | 0.36% | หุ้น |
| RHUMBLINE ADVISERS | $150,435,689 | 545,690 | 0.35% | หุ้น |
| CANADA PENSION PLAN INVESTMENT BOARD | $148,808,756 | 539,788 | 0.34% | หุ้น |
| PRUDENTIAL FINANCIAL INC | $141,115,078 | 511,880 | 0.32% | หุ้น |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $140,128,144 | 508,300 | 0.32% | สัญญาขายล่วงหน้า |
| California Public Employees Retirement System | $138,113,475 | 500,992 | 0.32% | หุ้น |
| WORLDQUANT MILLENNIUM ADVISORS LLC | $137,040,252 | 497,099 | 0.31% | หุ้น |
| Walleye Trading LLC | $136,103,216 | 493,700 | 0.31% | สัญญาซื้อล่วงหน้า |
| ENVESTNET ASSET MANAGEMENT INC | $131,134,728 | 475,677 | 0.30% | หุ้น |
| JANE STREET GROUP, LLC | $131,058,272 | 475,400 | 0.30% | สัญญาขายล่วงหน้า |
| MILLENNIUM MANAGEMENT LLC | $125,612,214 | 455,645 | 0.29% | หุ้น |
| Squarepoint Ops LLC | $124,438,920 | 451,389 | 0.29% | หุ้น |
| BANK OF AMERICA CORP /DE/ | $118,315,239 | 429,176 | 0.27% | หุ้น |
| LAKEWOOD CAPITAL MANAGEMENT, LP | $117,937,834 | 427,807 | 0.27% | หุ้น |
| GLENVIEW CAPITAL MANAGEMENT, LLC | $113,641,637 | 412,223 | 0.26% | หุ้น |
| MENORA MIVTACHIM HOLDINGS LTD. | $108,480,080 | 393,500 | 0.25% | หุ้น |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $108,208,205 | 405,654 | 0.25% | หุ้น |
| Man Group plc | $106,485,811 | 386,266 | 0.24% | หุ้น |
| JANE STREET GROUP, LLC | $102,359,984 | 371,300 | 0.24% | สัญญาซื้อล่วงหน้า |
| PARNASSUS INVESTMENTS, LLC | $99,345,699 | 360,366 | 0.23% | หุ้น |
| HSBC HOLDINGS PLC | $98,445,052 | 357,099 | 0.23% | หุ้น |
| JONES FINANCIAL COMPANIES LLLP | $97,924,160 | 346,279 | 0.22% | หุ้น |
| HighTower Advisors, LLC | $97,700,540 | 354,398 | 0.22% | หุ้น |
| Qube Research & Technologies Ltd | $95,895,839 | 347,852 | 0.22% | หุ้น |
| RENAISSANCE TECHNOLOGIES LLC | $95,247,164 | 345,499 | 0.22% | หุ้น |
| COOPERMAN LEON G | $89,596,000 | 325,000 | 0.21% | หุ้น |
| Universal- Beteiligungs- und Servicegesellschaft mbH | $88,633,118 | 321,070 | 0.20% | หุ้น |
| UBS Group AG | $85,150,936 | 308,876 | 0.20% | หุ้น |
| PRINCIPAL FINANCIAL GROUP INC | $84,423,968 | 306,239 | 0.19% | หุ้น |
| Connor, Clark & Lunn Investment Management Ltd. | $83,067,071 | 301,317 | 0.19% | หุ้น |
| Brandywine Global Investment Management, LLC | $83,043,221 | 301,723 | 0.19% | หุ้น |
| BARCLAYS PLC | $81,058,191 | 294,030 | 0.19% | หุ้น |
| NEW YORK STATE COMMON RETIREMENT FUND | $81,028,968 | 293,924 | 0.19% | หุ้น |
| CITADEL ADVISORS LLC | $80,415,856 | 291,700 | 0.18% | สัญญาซื้อล่วงหน้า |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | $77,231,334 | 284,500 | 0.18% | หุ้น |
| D. E. Shaw & Co., Inc. | $77,230,098 | 280,144 | 0.18% | หุ้น |
| FRANKLIN RESOURCES INC | $74,338,766 | 269,656 | 0.17% | หุ้น |
| BANK OF NOVA SCOTIA | $73,763,722 | 267,570 | 0.17% | หุ้น |
| CAPTRUST FINANCIAL ADVISORS | $73,593,768 | 266,954 | 0.17% | หุ้น |
| Quantinno Capital Management LP | $72,042,853 | 261,327 | 0.17% | หุ้น |
| LPL Financial LLC | $71,360,823 | 258,854 | 0.16% | หุ้น |
| ALLIANCEBERNSTEIN L.P. | $70,866,139 | 265,665 | 0.16% | หุ้น |
| JANE STREET GROUP, LLC | $70,403,434 | 255,381 | 0.16% | หุ้น |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | $69,152,270 | 259,240 | 0.16% | หุ้น |
| TD Asset Management Inc | $68,910,627 | 249,966 | 0.16% | หุ้น |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | $67,953,466 | 246,494 | 0.16% | หุ้น |
| AVIVA PLC | $66,917,736 | 242,737 | 0.15% | หุ้น |
| Susquehanna Portfolio Strategies, LLC | $65,143,735 | 236,302 | 0.15% | หุ้น |
| Korea Investment CORP | $64,741,794 | 234,844 | 0.15% | หุ้น |
| WOLVERINE TRADING, LLC | $64,525,530 | 225,110 | 0.15% | หุ้น |
| Nuveen Asset Management, LLC | $64,039,904 | 231,911 | 0.15% | หุ้น |
| PORTLAND INVESTMENT COUNSEL INC. | $62,303,680 | 226,000 | 0.14% | หุ้น |
| STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM | $60,990,065 | 221,235 | 0.14% | หุ้น |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | $60,432,000 | 219,209 | 0.14% | หุ้น |
| BARCLAYS PLC | $60,098,240 | 218,000 | 0.14% | สัญญาซื้อล่วงหน้า |
| Ensign Peak Advisors, Inc | $59,737,375 | 216,691 | 0.14% | หุ้น |
| CITADEL ADVISORS LLC | $58,912,816 | 213,700 | 0.14% | สัญญาขายล่วงหน้า |
| Walleye Trading LLC | $58,863,745 | 213,522 | 0.14% | หุ้น |
| FIRST TRUST ADVISORS LP | $57,187,000 | 207,440 | 0.13% | หุ้น |
ผู้บริหารบริษัท 40 รายชื่อผู้บริหาร · ผู้บริหาร 4 คน · กรรมการ 1 คน
| ผู้บริหารภายใน | บทบาท | กิจกรรมล่าสุด | หุ้นที่ถือครอง | ซื้อ 12 เดือน | ขาย 12 เดือน | สุทธิ 12 เดือน |
|---|---|---|---|---|---|---|
| Nicole S Jones | EVP, Chief Administrative Officer and Chief Human Resources Officer | 18 สิงหาคม 2026 S | 25,880 | 0 | 2 | $-6,118,100 |
| Bryan Holgerson | Title - President, Cigna Healthcare U.S. and EVP, Customer Health Outcomes | 6 สิงหาคม 2026 A | — | 0 | 0 | $0 |
| Jamie G Kates | Chief Accounting Officer | 12 มิถุนายน 2026 M | 2,368 | 0 | 1 | $-268,450 |
| Durga Prasad Koka | EVP, Global CIO | 1 มิถุนายน 2026 F | 6,552 | 0 | 0 | $0 |
| George Kurian | กรรมการ | 29 พฤษภาคม 2026 A | 3,778 | 0 | 0 | $0 |
| David Cordani | — | 3 พฤศจิกายน 2025 P | 157,935 | 1 | 0 | $999,932 |
| David J Brailer | — | 29 สิงหาคม 2025 F | 17,525 | 0 | 0 | $0 |
| Michael J Hennigan | — | 2 มิถุนายน 2025 A | 568 | 0 | 0 | $0 |
| Neesha Hathi | — | 23 เมษายน 2025 A | 3,369 | 0 | 0 | $0 |
| Philip Ozuah | — | 23 เมษายน 2025 A | 1,801 | 0 | 0 | $0 |
| Elder Granger | — | 23 เมษายน 2025 A | 6,109 | 0 | 0 | $0 |
| Mark B. Mcclellan | — | 23 เมษายน 2025 A | 6,109 | 0 | 0 | $0 |
| Kimberly A. Ross | — | 23 เมษายน 2025 A | 4,512 | 0 | 0 | $0 |
| Kathleen M Mazzarella | — | 23 เมษายน 2025 A | 6,109 | 0 | 0 | $0 |
| Donna F Zarcone | — | 23 เมษายน 2025 A | 26,735 | 0 | 0 | $0 |
| Eric C Wiseman | — | 23 เมษายน 2025 A | 23,158 | 0 | 0 | $0 |
| Eric J Foss | — | 23 เมษายน 2025 A | 35,914 | 0 | 0 | $0 |
| Noelle K Eder | — | 7 มีนาคม 2025 S | 13,406 | 0 | 0 | $0 |
| Brian C Evanko | — | 28 กุมภาพันธ์ 2025 A | 51,182 | 0 | 0 | $0 |
| Eric P Palmer | — | 28 กุมภาพันธ์ 2025 A | 66,160 | 0 | 0 | $0 |
| William J Delaney III | — | 19 สิงหาคม 2024 M | 17,539 | 0 | 0 | $0 |
| Michael W Triplett | — | 12 สิงหาคม 2024 M | 32,833 | 0 | 0 | $0 |
| Mary T Hoeltzel | — | 14 พฤษภาคม 2024 M | 2,595 | 0 | 0 | $0 |
| Cynthia Ryan | — | 30 สิงหาคม 2023 M | 5,937 | 0 | 0 | $0 |
| Everett Neville | — | 20 กรกฎาคม 2023 M | 5,987 | 0 | 0 | $0 |
| Paul A Sanford | — | 19 กรกฎาคม 2023 S | 8,679 | 0 | 0 | $0 |
| Jason D Sadler | — | 24 กุมภาพันธ์ 2023 A | 47,015 | 0 | 0 | $0 |
| Charles Berg | — | 8 กุมภาพันธ์ 2023 G | — | 0 | 0 | $0 |
| John Partridge | — | 26 เมษายน 2022 A | 28,177 | 0 | 0 | $0 |
| MURABITO JOHN M | — | 1 มีนาคม 2022 F | 51,226 | 0 | 0 | $0 |
| HARRIS ISAIAH JR | — | 30 พฤศจิกายน 2021 A | 20,015 | 0 | 0 | $0 |
| Matthew G Manders | — | 19 พฤศจิกายน 2021 F | 43,488 | 0 | 0 | $0 |
| Timothy C Wentworth | — | 12 พฤษภาคม 2021 G | 29,783 | 0 | 0 | $0 |
| Kristen Lauria | — | 30 เมษายน 2021 F | 2,785 | 0 | 0 | $0 |
| Steven B Miller | — | 26 กุมภาพันธ์ 2021 F | 28,439 | 0 | 0 | $0 |
| William L Roper | — | 26 กุมภาพันธ์ 2021 A | 8,583 | 0 | 0 | $0 |
| Roman Martinez IV | — | 30 พฤศจิกายน 2020 A | 48,839 | 0 | 0 | $0 |
| Mark L Boxer | — | 28 กุมภาพันธ์ 2020 F | 49,191 | 0 | 0 | $0 |
| ZOLLARS WILLIAM D | — | 13 กันยายน 2019 S | 13,500 | 0 | 0 | $0 |
| Lisa R Bacus | — | 1 มีนาคม 2019 F | 24,024 | 0 | 0 | $0 |
ผู้บริหารจากเอกสาร SEC Form 3/4/5; สุทธิ = เฉพาะการซื้อขายในตลาดเปิด
การถือครอง ETF ถือโดย ETF 242 ราย
น้ำหนักสะท้อนถึงการถือครองหุ้นโดยตรง (N-PORT) เท่านั้น กองทุนเลเวอเรจหรือกองทุนที่อิงตราสารอนุพันธ์อาจมีการเปิดรับความเสี่ยงจากสัญญาแลกเปลี่ยน (swap) เพิ่มเติมซึ่งไม่แสดง
| กองทุน | น้ำหนัก | หน่วย | ณ วันที่ | แหล่งที่มา |
|---|---|---|---|---|
| IHF · iShares Trust | 3.93% | 174,722 SH | 21 สิงหาคม 2026 | รายวัน |
| DUSA · Davis Fundamental ETF Trust | 3.26% | 130,244 NS | 30 เมษายน 2026 | N-PORT |
| MDPL · Northern Lights Fund Trust IV | 3.15% | 6,901 NS | 31 พฤษภาคม 2026 | N-PORT |
| MFSV · MFS Active Exchange Traded Funds Tr… | 2.77% | 47,358 NS | 31 พฤษภาคม 2026 | N-PORT |
| FXH · First Trust Exchange-Traded AlphaDE… | 2.36% | 70,938 NS | 30 เมษายน 2026 | N-PORT |
| MVFD · Northern Lights Fund Trust IV | 2.35% | 9,177 NS | 31 พฤษภาคม 2026 | N-PORT |
| SMRI · EA Series Trust | 2.01% | 37,417 NS | 30 เมษายน 2026 | N-PORT |
| LYLD · Cambria ETF Trust | 1.96% | 406 NS | 30 เมษายน 2026 | N-PORT |
| QDIV · Global X Funds | 1.89% | 2,232 NS | 31 พฤษภาคม 2026 | N-PORT |
| WBIL · Absolute Shares Trust | 1.86% | 2,057 NS | 30 มิถุนายน 2026 | N-PORT |
| BMVP · Invesco Exchange-Traded Fund Trust | 1.69% | 6,505 SH | 21 สิงหาคม 2026 | รายวัน |
| RUNN · Strategic Trust | 1.67% | 20,819 NS | 31 พฤษภาคม 2026 | N-PORT |
| QLTY · GMO ETF Trust | 1.60% | 260,100 NS | 31 พฤษภาคม 2026 | N-PORT |
| NUDV · Nushares ETF Trust | 1.59% | 2,485 NS | 30 เมษายน 2026 | N-PORT |
| RPV · Invesco Exchange-Traded Fund Trust | 1.55% | 97,920 SH | 21 สิงหาคม 2026 | รายวัน |
| GMOV · GMO ETF Trust | 1.53% | 5,024 NS | 31 พฤษภาคม 2026 | N-PORT |
| DWLD · Davis Fundamental ETF Trust | 1.53% | 29,890 NS | 30 เมษายน 2026 | N-PORT |
| RSPH · Invesco Exchange-Traded Fund Trust | 1.34% | 40,080 SH | 21 สิงหาคม 2026 | รายวัน |
| FBCV · FIDELITY COVINGTON TRUST | 1.29% | 7,062 NS | 30 เมษายน 2026 | N-PORT |
| RWL · Invesco Exchange-Traded Fund Trust … | 1.27% | 459,146 SH | 21 สิงหาคม 2026 | รายวัน |
| PWV · Invesco Exchange-Traded Fund Trust | 1.27% | 85,799 SH | 21 สิงหาคม 2026 | รายวัน |
| FHLC · FIDELITY COVINGTON TRUST | 1.25% | 123,144 NS | 30 เมษายน 2026 | N-PORT |
| FFLV · FIDELITY COVINGTON TRUST | 1.12% | 669 NS | 30 เมษายน 2026 | N-PORT |
| SPGP · Invesco Exchange-Traded Fund Trust | 1.11% | 92,344 SH | 21 สิงหาคม 2026 | รายวัน |
| IYH · iShares Trust | 1.11% | 155,756 SH | 21 สิงหาคม 2026 | รายวัน |
| CURE · Direxion Shares ETF Trust | 1.10% | 5,254 NS | 30 เมษายน 2026 | N-PORT |
| REVS · Columbia ETF Trust I | 1.07% | 10,450 NS | 30 เมษายน 2026 | N-PORT |
| VHT · VANGUARD WORLD FUND | 1.07% | 792,582 SH | 19 สิงหาคม 2026 | รายวัน |
| RXL · ProShares Trust | 1.06% | 2,747 NS | 31 พฤษภาคม 2026 | N-PORT |
| SYLD · Cambria ETF Trust | 1.01% | 33,396 NS | 30 เมษายน 2026 | N-PORT |
| RILA · Spinnaker ETF Series | 1.01% | 1,451 NS | 30 เมษายน 2026 | N-PORT |
| BRCE · MFS Active Exchange Traded Funds Tr… | 0.98% | 1,172 NS | 31 พฤษภาคม 2026 | N-PORT |
| PALC · Pacer Funds Trust | 0.97% | 7,697 NS | 30 เมษายน 2026 | N-PORT |
| PY · Principal Exchange-Traded Funds | 0.97% | 7,728 NS | 30 มิถุนายน 2026 | N-PORT |
| IMCV · iShares Trust | 0.96% | 41,362 SH | 21 สิงหาคม 2026 | รายวัน |
| FTA · First Trust Exchange-Traded AlphaDE… | 0.95% | 42,432 NS | 30 เมษายน 2026 | N-PORT |
| RFDA · ALPS ETF Trust | 0.95% | 2,980 NS | 31 พฤษภาคม 2026 | N-PORT |
| BSCS · Invesco Exchange-Traded Self-Indexe… | 0.89% | 30,937,177 | 21 สิงหาคม 2026 | รายวัน |
| IXJ · iShares Trust | 0.88% | 139,115 SH | 21 สิงหาคม 2026 | รายวัน |
| VLUE · iShares Trust | 0.87% | 310,167 SH | 21 สิงหาคม 2026 | รายวัน |
| EQIN · Columbia ETF Trust I | 0.83% | 7,926 NS | 30 เมษายน 2026 | N-PORT |
| VFVA · VANGUARD WELLINGTON FUND | 0.80% | 24,655 SH | 19 สิงหาคม 2026 | รายวัน |
| NULV · Nushares ETF Trust | 0.79% | 56,180 NS | 30 เมษายน 2026 | N-PORT |
| ACLC · AMERICAN CENTURY ETF TRUST | 0.77% | 8,508 NS | 31 พฤษภาคม 2026 | N-PORT |
| FCFY · First Trust Exchange-Traded Fund | 0.76% | 37 NS | 30 มิถุนายน 2026 | N-PORT |
| ASLV · ALLSPRING EXCHANGE-TRADED FUNDS TRU… | 0.72% | 5,530 NS | 30 เมษายน 2026 | N-PORT |
| UPSD · ETF Series Solutions | 0.67% | 2,343 NS | 30 เมษายน 2026 | N-PORT |
| SPVU · Invesco Exchange-Traded Fund Trust … | 0.65% | 3,174 NS | 31 พฤษภาคม 2026 | N-PORT |
| QARP · DBX ETF Trust | 0.64% | 1,727 NS | 29 พฤษภาคม 2026 | N-PORT |
| CVY · Invesco Exchange-Traded Fund Trust | 0.62% | 2,824 SH | 21 สิงหาคม 2026 | รายวัน |